UM  > Faculty of Health Sciences
Residential Collegefalse
Status已發表Published
Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival
Haapasalo A.1; Koponen E.1; Hoppe E.2; Wong G.1; Castren E.1
2001
Source PublicationBiochemical and Biophysical Research Communications
ISSN0006291X
Volume280Issue:5Pages:1352-1358
Abstract

Truncated trkB.T1 (TI) neurotrophin receptor inhibits full-length trkB.TK+ (TK+) signaling. At least two possible mechanisms have been proposed for this action: T1 could trap the ligand or function as a dominant negative receptor. To differentiate between these possibilities we have studied survival of serum-deprived PC12-trkB cells stably expressing TK+. PC12-trkB cells were observed to display constitutive trkB kinase activity which leads to survival of a cell subpopulation in the absence of added brain-derived neurotrophic factor (BDNF) and serum. Exogenous BDNF significantly increased cell survival, and this increase was inhibited by BDNF neutralizing antibody. The antibody treatment had no effect on the constitutive TK+ activity. Transfected T1 completely inhibited survival by BDNF or constitutive trkB kinase activity in PC12-trkB cells similarly to tyrosine kinase inhibitor K252a. In addition, T1 coimmunoprecipitated with TK+ and inhibited its autophosphorylation by BDNF. These data suggest that truncated T1 inhibits TK+ signaling by dominant negative action. © 2001 Academic Press.

KeywordBdnf K252a N2a Cell Pc12 Cell Tyrosine Phosphorylation
DOI10.1006/bbrc.2001.4296
URLView the original
Language英語English
WOS IDWOS:000167128500023
Scopus ID2-s2.0-0034816219
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionFaculty of Health Sciences
Affiliation1.Itä-Suomen yliopisto
2.Sanofi-Aventis Deutschland GmbH
Recommended Citation
GB/T 7714
Haapasalo A.,Koponen E.,Hoppe E.,et al. Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival[J]. Biochemical and Biophysical Research Communications, 2001, 280(5), 1352-1358.
APA Haapasalo A.., Koponen E.., Hoppe E.., Wong G.., & Castren E. (2001). Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochemical and Biophysical Research Communications, 280(5), 1352-1358.
MLA Haapasalo A.,et al."Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival".Biochemical and Biophysical Research Communications 280.5(2001):1352-1358.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Haapasalo A.]'s Articles
[Koponen E.]'s Articles
[Hoppe E.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Haapasalo A.]'s Articles
[Koponen E.]'s Articles
[Hoppe E.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Haapasalo A.]'s Articles
[Koponen E.]'s Articles
[Hoppe E.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.